Idiopathic pulmonary fibrosis
Conditions
Interventions
None listed
Sponsors
Hokkaido Study Group of Interstitial Lung Diseases
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The patient who showed an agreement of the participation to the study in a document by free will 2) Sex ; irrespective 3) Age ; 20 and over 4) In-/outpatient ; irrespective 5) The patient who was diagnosed as IPF according to the 4th version of the guideline of clinical diagnostic criteria for idiopathic interstitial pneumonia in Japan and who was authorized by Ministry of Health, Labour and Welfare specific disease 6) The patient who meets the 4th version of the guideline after the authorization
Exclusion criteria
Exclusion criteria: 1) The patient who has the evident cause of interstitial pneumonia such as collagen-vascular diseases, drug, environmental exposure, hypersensitivity pneumonitis, and infection. 2) The patient whom it was judged to be inadequate with HRCT. 3) The patient who has a malignant tumor or who had it with the past. 4) The patient who was judged to be inappropriate as an object of this study due to severe complications. 5) The patient who was judged to be inappropriate as an object of this study by a medical attendant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) survival time 2) progression-free survival time 3) onset of acute exacerbation of IPF 4) onset of malignancies including primary lung cancer | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) changes in pulmonary function test 2) PaO2 at rest and desaturation during 6-min walking test 3) changes of SP-D and KL-6 in sera 4) changes of symptoms | — |
Countries
Japan
Contacts
Public ContactMasanori Shiratori
Sapporo Medical University School of Medicine Department of Respiratory Medicine and Allergology
Outcome results
None listed